Inhibitors of Flaviviridae viruses
US8501714B2 · kind B2 · utility
3Cited by
6References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2010 |
| Grant date | Aug 6, 2013 |
| Priority date | — |
| Expiry date | Sep 7, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.